ERBB2 and breast carcinoma: Recurrent mutations in TP53 (p.H179R, p.R282W, p.R248Q, p.Y220C, p.R213X, p.R342X, p.Y163C, and p.C176Y) mainly occurred in the luminal B/HER2+, HER2+, and triple-negative subtypes of breast cancer (Supplementary Figs. 2 and 3a).